Scotrun, PA (PRWEB) June 9, 2006
Innovative preclinical software vendor PDS Pathology Data Systems, Ltd. recently announced additional licensing options for customers that wish to use this world-class software in a hosted and administration-free environment via the Internet.
“The enthusiasm with which our hosted options have been embraced is gratifying,” said Arthur Karakos, CEO of the vendor’s North America marketing and support group, Pathology Data Solutions Inc. “Not only are research universities and CROs enthused about being able to utilize the same powerful and flexible mission-critical software that is used by 7 of the 10 Top-Ten Pharma companies but, interestingly enough, so are biotech companies.” He went on to say, “They see the value of being able to use the exact same software solutions as many of the world’s finest pharmaceutical companies and CROs, but without the upfront costs-- plus they really like their ability to simply pay-as-they-go without impacting their capital budgets.”
The PathData System is the recognized gold standard for preclinical pathology, offering users a complete array of post-mortem functionalities-- from necropsy and histology to microscopy, statistics, tables, peer review, imaging and FDA-compliant final report generation. The ante-mortem aspects are covered by the company’s ToxData System for toxicology and clinical pathology and the new ReproData System for comprehensive reproductive toxicology and teratology. All three systems are tightly integrated and form the foundation of the PDS Preclinical Suite of products. The systems are modular and scalable to grow with the users, so they are an excellent option for the entire range of customers— from single users to global, multi-site organizations.
Differentiated from its competitors, PDS software solutions are neither operating system nor database-version dependent. In addition, the systems do not require any third-party products for statistical analysis, word processing or image capturing in order to function. All integrated statistics, imaging and reporting options are handled efficiently without the need to master additional software or rely on questionable external software life cycles that can cause havoc in a validated environment. Besides its traditional licensing options, PDS offers web-based options, as well. PDS provides a secure hosted GLP-compliant environment and maintains the GLP-applications in a validated state. A GLP certificate, mandatory for business, will be provided to customers to complete their validation documentation. This certification is unique in the industry and provides PDS customers’ Quality Assurance with significant peace of mind.
Organizations interested in learning how the Suite of Preclinical Systems can increase their efficiencies, decrease costs, ease the strain on resource usage and greatly reduce time-to-market are invited to contact PDS for more information.